Action Alert: Voluntary Withdrawal of IVIG Product

April 27, 2016

As part of HFA’s ongoing mission to assist and advocate for the bleeding disorders community, this action alert is being issued to keep you informed about blood safety. About This Withdrawal Due to increased reports of hypersensitivity reactions such as rashes or urticaria and/or wheezing, Octapharma USA Inc. has voluntarily withdrawn from the market one lot of […]

Sign up for E-mails, Dateline Magazine, and other ways to stay connected.